Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection

Biochem Biophys Res Commun. 2017 Nov 4;493(1):132-138. doi: 10.1016/j.bbrc.2017.09.063. Epub 2017 Sep 14.

Abstract

Human SMOOTHENED (SMO) was identified by expression cloning as a new host factor that inhibits HIV-1 infection. Forced expression of SMO inhibited HIV-1 replication and infection with a single-round lentiviral vector, but not infection with a murine leukemia virus-based retroviral vector in human MT-4 T cells. Quantitative PCR analyses revealed that stable expression of SMO impaired formation of the integrated form of lentiviral DNA, but did not interrupt reverse transcription. This inhibition was evident in MT-4 and HUT102 human T cell lines expressing low levels of SMO mRNA, but not in SupT1 or Jurkat T cell lines expressing higher levels of SMO mRNA. Depletion of SMO mRNA in Jurkat cells facilitated HIV-1 vector infection, suggesting that endogenous SMO plays a role in limiting lentiviral infection. These results suggest that SMO inhibits HIV-1 replication after completion of reverse transcription but before integration.

Keywords: HIV-1; Host factor; Infection; SMOOTHENED.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • Humans
  • Jurkat Cells
  • Smoothened Receptor / immunology*
  • Virus Internalization*
  • Virus Replication / immunology*

Substances

  • Smoothened Receptor